TAG:
care contracts
Pathology PPM Attempts Public Offering Of Shares
By R. Lewis Dark | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: AmeriPath’s efforts to become a public company make it the most visible management experiment in the pathology world today. Already considered controversial by many pathologists, should AmeriPath successfully pull off its proposed initial public stock offering, it will assu…
Tennessee Lab Network To Become Operational
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Although news of regional laboratory networks disappeared from the pages of lab industry publications, the movement is far from dead. In Tennessee, 13 hospital laboratories are about to launch the Middle Tennessee Healthcare Network. Organizers believe they have solutions to …
Innovative Approach Promises Integration of Clinical Lab Data
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Any laboratory executive with several years in the business has confronted the limitations of laboratory information system (LIS) software. For a variety of reasons, LIS software seldom delivers the full range of benefits and cost-effectiveness sought by laboratories. But in …
Joint Venture In Phoenix To Be Copied Elsewhere
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…
National Lab Strategies Will Impact Competitors
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Not since the era of commercial lab consolidation ended has such a significant trend emerged. As the three national labs eliminate service to unprofitable accounts, profound changes will occur to the market for laboratory and pathology services. How quickly this leads to impr…
Regional Lab Systems Beginning To Emerge
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: Regionalization of laboratory services is about to become a dominant industry trend. Four groups of players will drive this process and each needs to recruit hospital laboratories to participate in their regional model. This is the first generation of attempts to create finan…
New Hybrid Lab Systems Provide Peek At Future
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: As the first generation of regional laboratory systems begin operation, the marketplace is about to separate winners from losers. Stakes are high for hospital laboratory administrators. If they choose to affiliate with the wrong model, the consequences can cause extended disr…
Success Seems Elusive To Pathology Innovators
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Attempts to organize pathology practice management companies encounter resistance and market impediments. Success requires an astute business plan and a sophisticated management team to convince pathologists to abandon proven practice models and affiliate with regional or nat…
Laboratory War College To Highlight Innovation
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Quickly establishing itself as the premiere event for the management of clinical laboratories, this year’s Executive War College in New Orleans offers specialized advice and experience for laboratory administrators. Expect to hear the first public presentations about innova…
Unilab Pushes Insurers To Increase Cap Rates
By Robert Michel | From the Volume IV No. 3 – February 17, 1997 Issue
CEO SUMMARY: California’s financially destructive capitation rates plunged two more laboratories into bankruptcy. Unilab’s actions indicate that even the largest laboratory company in the state can no longer survive without reimbursement relief. The question remains as to whether mana…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized